1. Home
  2. SGA vs TELO Comparison

SGA vs TELO Comparison

Compare SGA & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGA
  • TELO
  • Stock Information
  • Founded
  • SGA 1986
  • TELO 2021
  • Country
  • SGA United States
  • TELO United States
  • Employees
  • SGA N/A
  • TELO N/A
  • Industry
  • SGA Broadcasting
  • TELO
  • Sector
  • SGA Consumer Discretionary
  • TELO
  • Exchange
  • SGA Nasdaq
  • TELO NYSE
  • Market Cap
  • SGA 74.2M
  • TELO 79.2M
  • IPO Year
  • SGA 1992
  • TELO 2024
  • Fundamental
  • Price
  • SGA $12.25
  • TELO $1.95
  • Analyst Decision
  • SGA
  • TELO
  • Analyst Count
  • SGA 0
  • TELO 0
  • Target Price
  • SGA N/A
  • TELO N/A
  • AVG Volume (30 Days)
  • SGA 4.1K
  • TELO 146.2K
  • Earning Date
  • SGA 05-08-2025
  • TELO 05-14-2025
  • Dividend Yield
  • SGA 8.16%
  • TELO N/A
  • EPS Growth
  • SGA N/A
  • TELO N/A
  • EPS
  • SGA 0.55
  • TELO N/A
  • Revenue
  • SGA $111,837,000.00
  • TELO N/A
  • Revenue This Year
  • SGA N/A
  • TELO N/A
  • Revenue Next Year
  • SGA $5.04
  • TELO N/A
  • P/E Ratio
  • SGA $22.43
  • TELO N/A
  • Revenue Growth
  • SGA N/A
  • TELO N/A
  • 52 Week Low
  • SGA $10.75
  • TELO $1.88
  • 52 Week High
  • SGA $18.19
  • TELO $8.40
  • Technical
  • Relative Strength Index (RSI)
  • SGA 55.44
  • TELO 31.42
  • Support Level
  • SGA $11.88
  • TELO $2.01
  • Resistance Level
  • SGA $12.45
  • TELO $2.19
  • Average True Range (ATR)
  • SGA 0.45
  • TELO 0.21
  • MACD
  • SGA 0.02
  • TELO -0.02
  • Stochastic Oscillator
  • SGA 71.43
  • TELO 7.49

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: